Stephanie Plaines - Dec 29, 2023 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Stock symbol
CLX
Transactions as of
Dec 29, 2023
Transactions value $
$0
Form type
4
Date filed
1/3/2024, 04:47 PM
Previous filing
Oct 3, 2023
Next filing
Apr 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +14.2 +0.91% $0.00 1.58K Nov 9, 2023 Common Stock 14.2 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +1.12K +70.8% $0.00 2.7K Dec 29, 2023 Common Stock 1.12K Direct F1, F3, F4
transaction CLX Deferred Stock Units Award $0 +184 +6.83% $0.00 2.88K Dec 29, 2023 Common Stock 184 Direct F1, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
F5 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.